Aerobiotix, Inc. Launches Novel Air Disinfection Technology

Aerobiotix, Inc. announces the launch of a novel product for high-flow air disinfection in commercial, life science, and healthcare settings. The device, called the Aerobiotix® T1 Air Disinfector-Recirculator, is a mobile unit designed to be deployed in enclosed spaces requiring a significant reduction in airborne microbial load. The system rapidly draws in contaminated room air, inactivates airborne viruses, spores and bacteria via an internal ultraviolet field, and recirculates the cleaned air back into the room.

Air quality in healthcare and life science settings has been an underappreciated issue, says company founder and physician-inventor David Kirschman, MD, who became concerned about healthcare air quality, particularly contamination with antibiotic-resistant organisms. From the crowded waiting room, to the busy operating room, air quality is a major contributor to overall quality of care. This technology will finally allow quality-focused stakeholders to become proactive and commit to best practices in air quality in their facilities, says Kirschman. The T1 system also has applications in laboratory, commercial and biodefense environments.

The T1 Air Disinfector-Recirculator was independently tested at the Research Triangle Institute Center for Microbial Community Systems and Health Research, and was found to eliminate 100 percent of viruses, 99.97 percent of bacteria and 99.91 percent of spores in a single pass through the unit. This was achieved at an airflow rate of 450 cubic feet of per minute, which is enough velocity to disinfect a 20-foot by 20-foot room in about 8 minutes.

The Aerobiotix T1 system utilizes a patent-pending reactor technology that dramatically increases the efficacy of ultraviolet exposure and the efficiency of its microbe inactivation effects. This 3D-UV reactor technology forces the airflow under pressure through a matrix of thousands of crystalline lenses. Simultaneously, multiple ultraviolet sources irradiate this matrix. The effect is to increase the density of the ultraviolet field while entrapping and killing microbes in the matrix. Because of this novel design, the T1 system can inactivate airborne microbes at much higher airflow rates and with greater efficiency than other technologies.

Source: Aerobiotix, Inc.